Septra DS Dosing for Pediatric UTI
For a 7-year-old female weighing 19.8 kg with a UTI, the appropriate dose of trimethoprim-sulfamethoxazole (Septra DS) is approximately 80 mg of trimethoprim (TMP) component twice daily, which translates to one-half of a double-strength tablet twice daily for 7-10 days.
Dose Calculation
The pediatric dosing for UTI is based on 8 mg/kg/day of the trimethoprim component divided into 2 doses 1:
- Weight: 19.8 kg
- Total daily TMP dose: 19.8 kg × 8 mg/kg = 158.4 mg/day
- Divided dose: 158.4 mg ÷ 2 = 79.2 mg per dose (approximately 80 mg)
Since one Septra DS tablet contains 160 mg TMP/800 mg SMX, this patient requires one-half DS tablet twice daily.
Duration of Therapy
Treat for 7-10 days 1. The AAP Pediatrics guideline specifically recommends 7-14 days for febrile UTI in young children, with evidence supporting that courses shorter than 7 days are inferior 1. For a 7-year-old with uncomplicated UTI, 7-10 days is appropriate, with the shorter duration preferred if clinical response is good.
Key Considerations
Local Resistance Patterns
Critical caveat: TMP-SMX should only be used if local E. coli resistance rates are <20% 2. If local resistance exceeds this threshold or is unknown, consider alternative agents such as cephalosporins (cephalexin 25-50 mg/kg/day in 4 divided doses) 1.
Practical Dosing
The FDA label 3 provides weight-based guidance confirming that children 15-22 kg should receive 1 regular-strength tablet (80 mg TMP/400 mg SMX) every 12 hours, which is equivalent to one-half DS tablet twice daily.
Alternative Formulation
If splitting DS tablets is impractical, prescribe one regular-strength tablet (80 mg TMP/400 mg SMX) twice daily, which provides the same dose and may be easier for caregivers to administer accurately.
Monitoring
Ensure adequate hydration during treatment. While serious adverse effects are rare in children, be aware that TMP-SMX can cause hyperkalaemia and acute kidney injury, particularly in patients with renal impairment 4, though this is primarily a concern in elderly patients.